Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial caco-2 cells

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 6, 2014, Pages 1301-1309

  Li, Zheng ^a   Gu, Liwei ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

EGCG; nanoparticles; ovalbumin; ovalbumin dextran conjugates

Indexed keywords

BIOCHEMISTRY; DEXTRAN; ENZYMES; MONOLAYERS; PARTICLE SIZE; SELF ASSEMBLED MONOLAYERS; SUSPENSIONS (FLUIDS);

EGCG; EPIGALLOCATECHIN GALLATE; EPITHELIAL CACO-2 CELLS; NANOPARTICLE SYSTEMS; NUTRACEUTICAL COMPOUNDS; OVALBUMINS; SIMULATED GASTRIC FLUID (SGF); SPHERICAL MORPHOLOGIES;

NANOPARTICLES;

CATECHIN; DEXTRAN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; GLUTARALDEHYDE; NANOPARTICLE; OVALBUMIN; OVALBUMIN DEXTRAN; OVALBUMIN-DEXTRAN;

ARTICLE; CACO 2 CELL LINE; CHEMISTRY; DIGESTION; DRUG STABILITY; GASTROINTESTINAL TRACT; GLYCATION; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; PARTICLE SIZE; PH;

CACO-2 CELLS; CATECHIN; DEXTRANS; DIGESTION; DRUG STABILITY; GASTROINTESTINAL TRACT; GLUTARAL; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MAILLARD REACTION; NANOPARTICLES; OVALBUMIN; PARTICLE SIZE;

EID: 84894161947     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf404621f     Document Type: Article

References (43)

1. Jung, Y. D.; Kim, M. S.; Chay, K. O.; Ahn, B. W.; Liu, W.; Bucana, C. D.; Gallick, G. E.; Ellis, L. M. EGCG, a major component of gree tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells Br. J. Cancer 2001, 84, 844-850
2. Annabi, B.; Bouzeghrane, M.; Moumdjian, R.; Moghrabi, A.; Béliveau, R. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg J. Neurochem. 2005, 94, 906-916
3. Chung, L. Y.; Cheung, T. C.; Kong, S. K.; Fung, K. P.; Choy, Y. M.; Chan, Z. Y.; Kwok, T. T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells Life Sci. 2001, 68, 1207-1214
4. Ahn, W. S.; Huh, S. W.; Bae, S.-M.; Lee, I. P.; Lee, J. M.; Namkoong, S. E.; Kim, C. K.; Sin, J.-I. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G1 arrest, and regulation of gene expression DNA Cell Biol. 2003, 22, 217-224
5. Kemberling, J. K.; Hampton, J. A.; Keck, R. W.; Gomez, M. A.; Selman, S. H. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate J. Urol. 2003, 170, 773-776
6. Nagle, D. G.; Ferreira, D.; Zhou, Y.-D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives Phytochemistry 2006, 67, 1849-1855
7. Zhu, M.; Chen, Y.; Li, R. C. Oral absorption and bioavailability of tea catechins Planta Med. 2000, 66, 444-447
8. Nakagawa, K.; Miyazawa, T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat J. Nutr. Sci. Vitaminol. 1997, 43, 679-684
9. Yang, C. S.; Chen, L.; Lee, M. J.; Balentine, D.; Kuo, M. C.; Schantz, S. P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers Cancer Epidemiol. Biomarkers Prev. 1998, 7, 351-354
10. Acosta, E. Bioavailability of nanoparticles in nutrient and nutraceutical delivery Curr. Opin. Colloid Interface Sci. 2009, 14, 3-15
11. Roger, E.; Lagarce, F.; Garcion, E.; Benoit, J.-P. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery Nanomedicine 2010, 5, 287-306
12. des Rieux, A.; Fievez, V.; Garinot, M.; Schneider, Y.-J.; Préat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Controlled Release 2006, 116, 1-27
13. Li, Z.; Percival, S. S.; Bonard, S.; Gu, L. Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects Mol. Nutr. Food Res. 2011, 55, 1096-1103
14. Zhao, D.; Zhao, X.; Zu, Y.; Li, J.; Zhang, Y.; Jiang, R.; Zhang, Z. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles Int. J. Nanomed. 2010, 5, 669-677
15. Zou, T.; Li, Z.; Percival, S. S.; Bonard, S.; Gu, L. Fabrication, characterization, and cytotoxicity evaluation of cranberry procyanidins-zein nanoparticles Food Hydrocolloids 2012, 27, 293-300
16. Li, Z.; Gu, L. Effects of mass ratio, pH, temperature, and reaction time on fabrication of partially purified pomegranate ellagitannin-gelatin nanoparticles J. Agric. Food Chem. 2011, 59, 4225-4231
17. Yi, K.; Cheng, G.; Xing, F. Gelatin/tannin complex nanospheres via molecular assembly J. Appl. Polym. Sci. 2006, 101, 3125-3130
18. Capanni, C.; Taddei, N.; Gabrielli, S.; Messori, L.; Orioli, P.; Chiti, F.; Stefani, M.; Ramponi, G. Investigation of the effects of copper ions on protein aggregation using a model system Cell. Mol. Life Sci. 2004, 61, 982-991
19. Luo, Y.; Zhang, B.; Whent, M.; Yu, L.; Wang, Q. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study Colloids Surf. B: Biointerfaces 2011, 85, 145-152
20. Cuccioloni, M.; Sparapani, L.; Amici, M.; Lupidi, G.; Eleuteri, A. M.; Angeletti, M. Kinetic and equilibrium characterization of the interaction between bovine trypsin and I-ovalbumin Biochim. Biophys. Acta-Proteins Proteomics 2004, 1702, 199-207
21. Martos, G.; Contreras, P.; Molina, E.; López-Fandiño, R. Egg white ovalbumin digestion mimicking physiological conditions J. Agric. Food Chem. 2010, 58, 5640-5648
22. Moncrief, J. A.; Darin, J. C.; Canizaro, P. C.; Sawyer, R. B. Use of dextran to prevent arterial and venous thrombosis Ann. Surg. 1963, 158, 553-559
23. de Raucourt, E.; Mauray, S.; Chaubet, F.; Maiga-Revel, O.; Jozefowicz, M.; Fischer, A. M. Anticoagulant activity of dextran derivatives J. Biomed. Mater. Res. 1998, 41, 49-57
24. Varga, R.; Török, L.; Szabó, A.; Kovács, F.; Keresztes, M.; Varga, G.; Kaszaki, J.; Boros, M. Effects of colloid solutions on ischemia-reperfusion-induced periosteal microcirculatory and inflammatory reactions: comparison of dextran, gelatin, and hydroxyethyl starch Crit. Care Med. 2008, 36, 2828-2837
25. Sery, T. W.; Hehre, E. J. Degradation of dextrans by enzymes of intestinal bacteria. J. Bacteriol. 1956, 71, 373-380.
26. Jaeger, H.; Janositz, A.; Knorr, D. The Maillard reaction and its control during food processing. The potential of emerging technologies Pathol. Biol. 2010, 58, 207-213
27. Kato, A.; Sasaki, Y.; Furuta, R.; Kobayashi, K. Functional protein-polysaccharide conjugate prepared by controlled dry-heating of ovalbumin-dextran mixtures Agric. Biol. Chem. 1990, 54, 107-112
28. Choi, S. J.; Kim, H. J.; Park, K. H.; Moon, T. W. Molecular characteristics of ovalbumin-dextran conjugates formed through the Maillard reaction Food Chem. 2005, 92, 93-99
29. Zhang, L.; Zheng, Y.; Chow, M. S. S.; Zuo, Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model Int. J. Pharm. 2004, 287, 1-12
30. Zhou, H.; Sun, X.; Zhang, L.; Zhang, P.; Li, J.; Liu, Y.-N. Fabrication of biopolymeric complex coacervation core micelles for efficient tea polyphenol delivery via a green process Langmuir 2012, 28, 14553-14561
31. Deng, W.; Li, J.; Yao, P.; He, F.; Huang, C. Green preparation process, characterization and antitumor effects of doxorubicin-BSA-dextran nanoparticles Macromol. Biosci. 2010, 10, 1224-1234
32. Sun, G.; Shen, Y.-I.; Ho, C. C.; Kusuma, S.; Gerecht, S. Functional groups affect physical and biological properties of dextran-based hydrogels J. Biomed. Mater. Res. Part A 2010, 93A, 1080-1090
33. Jang, H.; Ryoo, S.-R.; Kostarelos, K.; Han, S. W.; Min, D.-H. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores Biomaterials 2013, 34, 3503-3510
34. Ensign, L. M.; Cone, R.; Hanes, J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Delivery Rev. 2012, 64, 557-570
35. Norris, D. A.; Puri, N.; Sinko, P. J. The effect of physical barriers and properties on the oral absorption of particulates Adv. Drug Delivery Rev. 1998, 34, 135-154
36. Shutava, T. G.; Balkundi, S. S.; Vangala, P.; Steffan, J. J.; Bigelow, R. L.; Cardelli, J. A.; O'Neal, D. P.; Lvov, Y. M. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols ACS Nano 2009, 3, 1877-1885
37. Mellet, P.; Michels, B.; Bieth, J. G. Heat-induced conversion of ovalbumin into a proteinase inhibitor J. Biol. Chem. 1996, 271, 30311-30314
38. Gao, S.; Hu, M. Bioavailability challenges associated with development of anti-cancer phenolics Mini Rev. Med. Chem. 2010, 10, 550-567
39. Walgren, R. A.; Walle, U. K.; Walle, T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells Biochem. Pharmacol. 1998, 55, 1721-1727
40. Shah, P.; Jogani, V.; Bagchi, T.; Misra, A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption Biotechnol. Prog. 2006, 22, 186-198
41. Wang, J.; Byrne, J. D.; Napier, M. E.; DeSimone, J. M. More effective nanomedicines through particle design Small 2011, 7, 1919-1931
42. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 2004, 377, 159-169
43. Hu, B.; Ting, Y.; Yang, X.; Tang, W.; Zeng, X.; Huang, Q. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability Chem. Commun. 2012, 48, 2421-2423